Call for Papers: Annual Colloquium on Precision Oncology & Next-Gen Therapeutics (PrecisionOnco)

The organizing committee cordially invites oncologists, clinical researchers, pharmacologists, molecular biologists, and academic scholars to submit their research abstracts, clinical case studies, and systematic reviews for presentation at the Annual Colloquium on Precision Oncology & Next-Gen Therapeutics (PrecisionOnco), convening on October 14–15, 2027 in San Francisco, USA (Hybrid Format).

PrecisionOnco serves as a premier international summit dedicated to advancing global breakthroughs across precision cancer care, targeted therapeutics, molecular diagnostics, and next-generation oncology treatments.

Key Highlights & Participant Benefits:
Global Academic Exposure: Present your research to an international assembly of leading clinical investigators, oncology pioneers, and academic department heads.

Official Proceedings & DOI Indexing: All accepted abstracts will be published in official conference proceedings with certified DOI indexing for institutional academic appraisal.

Educational Contact Hours: Certified professional development units provided for institutional reporting and professional compliance.

Flexible Participation: Options available for both in-person oral podium presentations in San Francisco and synchronous virtual streams.

Important Submission Guidelines:
Submission Deadline: July 15, 2027

Abstract Registration Due: July 30, 2027

Scope & Tracks: We welcome submissions spanning precision oncology, biomarker-driven therapies, immunotherapy, genomic profiling, and targeted cancer clinical trials.

To submit your abstract or review registration tiers, please visit our official conference web portal or reach out directly to the scientific secretariat at info@precision.catalystcolloquia.org